3-(2,4-Dihydroxy-6-methoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one

Catalog No.: 
ACCPEB591
CAS No.: 
119425-91-1
Molecular Formula: 
C16H16O5
Molecular Weight: 
288.30
3-(2,4-Dihydroxy-6-methoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$100.00InquiryInquiry
10mg99%$150.00In stockInquiry
25mg99%$284.00InquiryInquiry
50mg99%$481.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2,4-Dihydroxy-6-methoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one
IUPAC Name3-(2,4-dihydroxy-6-methoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one
MDL No.-
Molecular FormulaC16H16O5
Molecular Weight288.30
SMILESO=C(C1=CC=C(O)C=C1)CCC2=C(OC)C=C(O)C=C2O
InChI KeyAQMBVNGTZRFEPF-UHFFFAOYSA-N
Synonym1-Propanone, 3-(2,4-dihydroxy-6-methoxyphenyl)-1-(4-hydroxyphenyl)-;Loureirin D;3-(2,4-Dihydroxy-6-methoxyphenyl)-1-(4-hydroxyphenyl)propan-1-one;Loureirin D, 10 mM in DMSO
CAS No.119425-91-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACCPEB591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPEB591 route product structure diagram
    ACCPEB591119425-91-1In Stock
Inquiry

2. ACCPEB591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPEB591 route product structure diagram
    ACCPEB591119425-91-1In Stock
Inquiry

3. ACCPEB591 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPEB591 route product structure diagram
    ACCPEB591119425-91-1In Stock
Inquiry

Comments (0)